Concepedia

1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Takashi Muramatsu, Yoshinobu Onuma, Robert‐Jan van Geuns, Bernard Chevalier, Tejas Patel, Ashok Seth, Roberto Diletti, Héctor M. García‐García, Cécile Dorange, Susan Veldhof,

JACC: Cardiovascular Interventions · 2014 · 51 citations · 32 references

DOI

Concepts

References

32

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa et al. · New England Journal of Medicine · 1998 · 7.1K citations · Full text

, , +17

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

, , +13

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

Jeremiah Stamler, Olga Vaccaro, James D. Neaton et al. · Diabetes Care · 1993 · 4.1K citations

, , +14

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Circulation · 2011 · 3.3K citations · Full text

, , +14

Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

William Wijns, N Danchin, Carlo Di Mario et al. · European Heart Journal · 2010 · 3.2K citations · Full text

, , +16